A startup utilizing digital holography technology to measure the minute three-dimensional shapes of objects with high precision and speed. It contributes to improving quality control for semiconductors and space equipment, enabling efficient precision measurement through non-contact and non-destructive methods.
独自デジタルホログラフィ技術を活用して半導体・宇宙といった先端産業における精密測定装置を開発する株式会社Holoway（所在地：兵庫県神戸市、代表取締役：佐藤邦弘、以下「Holoway」）は、シリーズAとして総額...
[画像1: https://prtimes.jp/i/140458/2/resize/d140458-2-ff95c28ff64e5a3ee559-1.jpg ] 株式会社Holoway（神戸市、以下「Holoway」）は、シードラウンドにてQB第二号投資事業有限責任組合（GP：QBキャピタル...
Focusing on microvascular disorders throughout the body, we have developed the world's first “vascular endothelial stem cells” as a cell-based therapeutic agent, providing a novel vascular regeneration treatment to reduce the risk of heart disease and dementia.
A startup developing a tooth regeneration drug that enables the regeneration of missing teeth in congenital anodontia by utilizing neutralizing antibodies that suppress molecules inhibiting tooth germ growth.
A Tokushima University-spinoff startup developing digital dental crown technology that treats teeth without grinding healthy enamel. By designing crowns that only replace necessary parts, it provides solutions to dental clinics, with adoption at 250 clinics nationwide, contributing to reduced patient costs and improved treatment precision.
A startup advancing drug discovery through proprietary platform technology that selectively delivers drugs to immune cells, both through in-house development and collaborative partnerships. It aims to create novel therapies for intractable diseases by controlling immune responses.